SCM
Superstring Capital Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,379,556
| Closed | -$2.28M | – | 38 |
|
|
2024
Q4 | $2.28M | Sell |
1,379,556
-87,378
| -6% | -$144K | 1.97% | 15 |
|
|
2024
Q3 | $5.13M | Buy |
1,466,934
+969,574
| +195% | +$3.39M | 4.49% | 9 |
|
|
2024
Q2 | $1.63M | Sell |
497,360
-423,116
| -46% | -$1.39M | 2.06% | 13 |
|
|
2024
Q1 | $6.76M | Buy |
920,476
+72,653
| +9% | +$533K | 4.47% | 7 |
|
|
2023
Q4 | $3.17M | Buy |
+847,823
| New | +$3.17M | 2.26% | 16 |
|